X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
female (17) 17
humans (17) 17
middle aged (12) 12
pathology (12) 12
oncology (11) 11
adult (10) 10
immunohistochemistry (9) 9
tumors (9) 9
cancer (8) 8
aged (7) 7
article (7) 7
biomarkers, tumor - genetics (6) 6
carcinoma (6) 6
mutation (6) 6
obstetrics & gynecology (6) 6
prognosis (6) 6
aged, 80 and over (5) 5
endometrial neoplasms - pathology (5) 5
genes (5) 5
ovarian neoplasms - pathology (5) 5
surgery (5) 5
cystadenocarcinoma, serous - pathology (4) 4
diagnosis, differential (4) 4
genetic aspects (4) 4
male (4) 4
metastasis (4) 4
mutations (4) 4
neoplasm grading (4) 4
ovarian cancer (4) 4
adolescent (3) 3
biopsy (3) 3
borderline tumors (3) 3
braf (3) 3
diagnosis (3) 3
endometrial cancer (3) 3
endometrial neoplasms - genetics (3) 3
endometrium (3) 3
expression (3) 3
gene mutations (3) 3
genomics (3) 3
high-throughput nucleotide sequencing (3) 3
in situ hybridization, fluorescence (3) 3
low-grade serous carcinoma (3) 3
massively parallel sequencing (3) 3
multiprocessing (3) 3
oncogene proteins, fusion - genetics (3) 3
ovarian neoplasms - genetics (3) 3
serous borderline tumour (3) 3
somatic mutations (3) 3
translocation (3) 3
tumor proteins (3) 3
adenocarcinoma, clear cell - pathology (2) 2
aggressive behavior (2) 2
analysis (2) 2
bcor (2) 2
breast neoplasms - secondary (2) 2
care and treatment (2) 2
cell biology (2) 2
child (2) 2
classification (2) 2
clear-cell sarcoma (2) 2
cystadenocarcinoma, serous - genetics (2) 2
dna (2) 2
endometrial stromal sarcoma (2) 2
follow-up studies (2) 2
gata3 (2) 2
gene sequencing (2) 2
genetic research (2) 2
genomes (2) 2
heterogeneity (2) 2
hnf-1β (2) 2
immunohistochemical analysis (2) 2
immunohistochemical expression (2) 2
kras (2) 2
lesions (2) 2
low-grade (2) 2
low‐grade serous carcinoma (2) 2
melanoma (2) 2
metastases (2) 2
molecular analysis (2) 2
mutation - genetics (2) 2
myxoid leiomyosarcoma (2) 2
neoplasms (2) 2
neoplasms - genetics (2) 2
neuroblastoma (2) 2
obstetrics and gynecology (2) 2
ovarian neoplasms - diagnosis (2) 2
ovary (2) 2
patients (2) 2
peritoneal neoplasms - pathology (2) 2
polycomb repressor complex (2) 2
predictive value of tests (2) 2
proteins (2) 2
proto-oncogene proteins - genetics (2) 2
proto-oncogene proteins b-raf - genetics (2) 2
repressor proteins - genetics (2) 2
research (2) 2
rna-binding proteins - genetics (2) 2
sarcoma, endometrial stromal - genetics (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human mutation, ISSN 1059-7794, 08/2019
Fumarate hydratase (FH) mutations underpin the autosomal recessive syndrome. FH deficiency and the autosomal dominant syndrome hereditary leiomyomatosis and... 
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2019, Volume 154, Issue 3, pp. 516 - 523
AbstractObjectiveEndometrioid ovarian carcinomas (EOCs) comprise 5–10% of all ovarian cancers and commonly co-occur with synchronous endometrioid endometrial... 
Hematology, Oncology, and Palliative Medicine | Obstetrics and Gynecology | Massively parallel sequencing | Heterogeneity | Endometrioid ovarian cancer | Molecular subtypes | Somatic mutations | INHIBITION | ONCOLOGY | DNA | MUTATIONAL LANDSCAPE | CANCER | OBSTETRICS & GYNECOLOGY | Endometrial cancer | Tumor proteins | Multiprocessing | Analysis | Genomics | Ovarian cancer
Journal Article
Obstetrical & Gynecological Survey, ISSN 0029-7828, 08/2019, Volume 74, Issue 8, pp. 473 - 474
(Abstracted from JCO Precision Oncology 2019; doi10.1200/PO.18.00338)Endometrial cancer remains the most common gynecologic malignancy. Fortunately,... 
Journal Article
Human Pathology, ISSN 0046-8177, 06/2019, Volume 88, pp. 87 - 91
As immune checkpoint inhibitors are rapidly developing into the standard of care for patients with advanced melanoma, the value of diagnostic metrics to... 
PD-L1 | PD-L2 | 9p24.1 amplification | JAK2 | Immunotherapy | Melanoma | LYMPHOMA | PATHOLOGY | NIVOLUMAB | BLOCKADE | EXPRESSION | Metastasis | Drug therapy | Genes | Genomes | FDA approval | Patients | Proteins | Lymphocytes | Response rates | Biomarkers | Ligands | Lymphomas | Mutation | Signatures | Tumors
Journal Article
International Journal of Gynecological Pathology, ISSN 0277-1691, 05/2019, Volume 38, Issue 3, pp. 263 - 275
Journal Article
by Latham, Alicia and Latham, Alicia and Srinivasan, Preethi and Srinivasan, Preethi and Kemel, Yelena and Kemel, Yelena and Shia, Jinru and Shia, Jinru and Bandlamudi, Chaitanya and Bandlamudi, Chaitanya and Mandelker, Diana and Mandelker, Diana and Middha, Sumit and Middha, Sumit and Hechtman, Jaclyn and Hechtman, Jaclyn and Zehir, Ahmet and Zehir, Ahmet and Dubard-Gault, Marianne and Dubard-Gault, Marianne and Tran, Christina and Tran, Christina and Stewart, Carolyn and Stewart, Carolyn and Sheehan, Margaret and Sheehan, Margaret and Penson, Alexander and Penson, Alexander and DeLair, Deborah and DeLair, Deborah and Yaeger, Rona and Yaeger, Rona and Vijai, Joseph and Vijai, Joseph and Mukherjee, Semanti and Mukherjee, Semanti and Galle, Jesse and Galle, Jesse and Dickson, Mark A and Dickson, Mark A and Janjigian, Yelena and Janjigian, Yelena and O’Reilly, Eileen M and O'Reilly, Eileen M and Segal, Neil and Segal, Neil and Saltz, Leonard B and Saltz, Leonard B and Reidy-Lagunes, Diane and Reidy-Lagunes, Diane and Varghese, Anna M and Varghese, Anna M and Bajorin, Dean and Bajorin, Dean and Carlo, Maria I and Carlo, Maria I and Cadoo, Karen and Cadoo, Karen and Walsh, Michael F and Walsh, Michael F and Weiser, Martin and Weiser, Martin and Aguilar, Julio Garcia and Aguilar, Julio Garcia and Klimstra, David S and Klimstra, David S and Diaz, Luis A and Diaz, Luis A and Baselga, Jose and Baselga, Jose and Zhang, Liying and Zhang, Liying and Ladanyi, Marc and Ladanyi, Marc and Hyman, David M and Hyman, David M and Solit, David B and Solit, David B and Robson, Mark E and Robson, Mark E and Taylor, Barry S and Taylor, Barry S and Offit, Kenneth and Offit, Kenneth and Berger, Michael F and Berger, Michael F and Stadler, Zsofia K and Stadler, Zsofia K
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4, pp. 286 - 295
PURPOSE Microsatellite instability (MSI) and/or mismatch repair deficiency (MMR-D) testing has traditionally been performed in patients with colorectal (CRC)... 
GERMLINE | MSH2 | ONCOLOGY | NONPOLYPOSIS COLORECTAL-CANCER | PREDISPOSITION | GENES | RISK | MUTATIONS | TUMORS | MISMATCH REPAIR DEFICIENCY | IMMUNOHISTOCHEMISTRY | ORIGINAL REPORTS
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2018, Volume 24, Issue 23, pp. 5939 - 5947
Purpose: Advanced-stage endometrial cancers have limited treatment options and poor prognosis, highlighting the need to understand genetic drivers of... 
SOLID TUMORS | ONCOLOGY | MUTATIONS
Journal Article
Human pathology, 09/2018
As immune checkpoint inhibitors are rapidly developing into the standard of care for patients with advanced melanoma, the value of diagnostic metrics to... 
Journal Article
Histopathology, ISSN 0309-0167, 09/2018, Volume 73, Issue 3, pp. 438 - 443
Aims The most common BRAF mutation in ovarian low‐grade serous neoplasms (LGSNs) involves substitution of valine by glutamic acid at position 600 (V600E).... 
low‐grade serous carcinoma | VE1 immunohistochemistry | ovary | BRAFV600E mutation | serous borderline tumour | Immunohistochemistry | Monoclonal antibodies | Genetic aspects | Metastasis | Gene mutations | Glutamate | Proteins | Glutamic acid | Carcinoma | Valine | Mutation | Paraffin | Metastases | Tumors | low-grade serous carcinoma
Journal Article
Histopathology, ISSN 0309-0167, 09/2018, Volume 73, Issue 3, pp. 438 - 443
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 02/2018, Volume 16, Issue 2, pp. 201 - 209
Endometrial cancers are the most common gynecologic malignancies. The staging of endometrial cancer has evolved from a clinical-based system to a comprehensive... 
FIGO GRADE | REPAIR PROTEIN EXPRESSION | RISK-FACTORS | ONCOLOGY | IMMUNOHISTOCHEMICAL ANALYSIS | MICROSATELLITE INSTABILITY | TUMOR MORPHOLOGY | UTERINE CORPUS | LOW-GRADE | UNDIFFERENTIATED CARCINOMA | CLINICOPATHOLOGICAL ANALYSIS
Journal Article
The Journal of Pathology, ISSN 0022-3417, 10/2017, Volume 243, Issue 2, pp. 230 - 241
Journal Article
The Journal of Pathology, ISSN 0022-3417, 10/2017, Volume 243, Issue 2, pp. 230 - 241
Journal Article
JCO precision oncology, ISSN 2473-4284, 2017, Volume 2017
Microsatellite instability (MSI)/mismatch repair (MMR) status is increasingly important in the management of patients with cancer to predict response to immune... 
Journal Article